- Supported exchanges /
- ST /
- CMOTEC-B.ST
Scandinavian ChemoTech AB Series B (CMOTEC-B ST) stock market data APIs
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Scandinavian ChemoTech AB Series B Financial Data Overview
| 1.91 | |
| 2.01 | |
| - | |
| 2.15 | |
| 2.03 | |
| 1.6-5.2 | |
| 40 619 K | |
| 21 692 K | |
| 5 160 K | |
| -0.1389 | |
| 1.32 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Scandinavian ChemoTech AB Series B Fundamental Data is available in our Financial Data APIs
- Net Revenue 5 160 K
- EBITDA -15 605 000
- Earnings Per Share -0.44
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Scandinavian ChemoTech AB Series B Earnings via APIs
- Latest Release 2024-11-05
- EPS/Forecast NaN
Get Scandinavian ChemoTech AB Series B End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
